Skip to main content

Animations

MJFF Publications

5381 - 5390 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2024
  • 2024
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2257
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2220
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Comparison between four published definitions of hyposmia in Parkinson's disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2258
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01240-4
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Development and evaluation of [125I]IPPI for Tau imaging in postmortem human Alzheimer's disease brain
    Journal Name: Synapse
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/syn.22183
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-023-02661-2
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscs
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02517-x
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mitofusin 2 displays fusion-independent roles in proteostasis surveillance
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56673-5
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-56293-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Derailed degradation: LRRK2-dependent exocytosis in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2515758122
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.